ACIP will reassess cumulative vaccine effects, older shotsnews2025-06-25T19:37:34+00:00June 25th, 2025|Endpoints News|
Acera Surgical Broadens Reach of Restrata ® with New FDA Clearance for Soft Tissue Reinforcementnews2025-06-25T14:57:03+00:00June 25th, 2025|Medical Device News Magazine|
FDA investigating Sarepta’s Duchenne gene therapy following patient deathsnews2025-06-25T07:56:00+00:00June 25th, 2025|Endpoints News|
Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantationnews2025-06-25T05:33:55+00:00June 25th, 2025|Medical Device News Magazine|
FDA hires former FDA scientist Michael Davis as CDER deputy directornews2025-06-24T19:20:16+00:00June 24th, 2025|Endpoints News|
RFK Jr. refutes that he guaranteed to keep ACIP’s rosternews2025-06-24T19:04:19+00:00June 24th, 2025|Endpoints News|
Sources: FDA chief Makary sought rejection of KalVista’s drugnews2025-06-24T17:31:56+00:00June 24th, 2025|Endpoints News|
Politics collide with science ahead of new ACIP meetingnews2025-06-23T20:26:17+00:00June 23rd, 2025|Endpoints News|
FDA approves AstraZeneca, Daiichi Sankyo’s Datroway in EGFR-mutated lung cancernews2025-06-23T20:03:02+00:00June 23rd, 2025|Endpoints News|
